Abstract 177: Clinical and Imaging Outcomes of Ophthalmic Aneurysm Flow Diversion with or without Adjunctive Coiling

Introduction Flow diversion (FD) is commonly used for the treatment of aneurysms involving the ophthalmic segment of the carotid artery (COA). The origin of the ophthalmic artery (OA) in relation to the aneurysm sac can affect recurrence and complications. We studied the effects of COA treatment with FD alone or in combination with coil embolization, based on the origin of the ophthalmic artery in‐relation to the aneurysm sac. Methods Retrospective analysis of a prospectively collected tertiary center database. Based on the ophthalmic artery origin, four types of carotid ophthalmic aneurysms were previously described and implemented in this study: OA originates from Type A. directly from the aneurysm fundus, B. aneurysm neck, C. inner curve of the carotid siphon, and D. OA separate from the aneurysm. Imaging outcomes were aneurysm occlusion and OA patency at 1‐year, determined by Digital Subtraction Angiography (DSA) or MRA. Clinical outcome was treatment‐related visual complications. Results A total of 60 patients treated at our tertiary center between January 2017 and November 2019 were reviewed. 4 patients were lost to follow up. Clinical and angiographic data of 59 COAs treated with FD +/‐ coil embolization were available. FD alone was used in 44 (75%) aneurysms, the rest had adjunct coiling. Median age was 55. Ten (17%) patients were men. Thirty two aneurysms (55%) were Type D, 22 (37%) Type B, 5 (8%) Type A. No Type C aneurysms were identified. Overall complete occlusion rate was 82%; 94% vs 71% for adjunct coiling vs FD only, respectively. Residual filling was seen in 4 (12%) Type D aneurysms, 8 (35%) Type B aneurysms, and 1 (20%) Type A aneurysm. The ophthalmic artery was occluded at follow up in all but one patient in Type A aneurysm group (80%), 2 (7.1%) in Type D, and 6 (27%) in Type B. 6/15 (40%) of patients in the adjunct coiling group had transient and short‐lasting disturbing visual symptoms, vs 7/44 (16%) in the FD only group. No patient had long‐term visual complications. A total of 10 patients showed OA occlusion at follow up, 4 of them in the adjunct coiling group (26%). There was 1 patient (2%) with a non‐disabling stroke due to antiplatelet therapy interruption and in‐stent thrombosis. Conclusion Flow diversion appears safe and effective for COA treatment. Adjunct coil embolization increased COA occlusion 1 year after FD treatment without significant increase in long‐term visual complications. Adjunct coiling and ophthalmic artery origin location appear to have a significant effect on treatment result, and should be considered at treatment planning.